Amelia Ehrens

Recent Posts

2013 Global Benchmarking Project Update from Fuld & Company

Posted by Amelia Ehrens on Mar 7, 2013 12:39:00 AM

Fuld & Company's 2013 Global Benchmarking Project Update has just been released and we invite you to download a complimentary copy.

Read More

Competitive Intelligence Insights Newsletter

Posted by Amelia Ehrens on Feb 18, 2013 9:36:00 AM

Subscribe to Fuld & Company's Competitive Intelligence Insights newsletter to receive CI insights in your mailbox! Emails are not sent more than one week and your email will not be shared.

Read More

How the biz world took a page from the CIA | Fortune

Posted by Amelia Ehrens on Dec 20, 2012 4:25:00 PM

By: Omar Akhtar

Companies use a variety of methods to stay one step ahead of their rivals. Competitive intelligence is one of the fastest growing ways to pull this off.

Read More

Topics: Competitive Intelligence, Brand Insights

Health services at Springs Creative include medicine, physicals, flu shots |

Posted by Amelia Ehrens on Dec 3, 2012 9:27:00 PM

December 3, 2012 | By Don Worthington

The number of on-site clinics nationally is expected to dramatically grow. A study by Fuld + Co., a Boston, Mass.-based research firm, estimated that by 2015 there could by 7,000 on-site clinics. Fuld + Co. estimates 10 percent of the U.S. population under age 65 will have its health-care needs met by employer on-site clinics by 2015.

Managing health care costs was a reason Springs Creative, Red Venture and the city of Rock Hill opted for on-site care.

Read More

Topics: Pharma, Healthcare, Life Sciences

Change is in the air between Consumer Healthcare and Food Companies

Posted by Amelia Ehrens on Aug 2, 2012 2:40:00 PM

The Nutraceuticals industry has finally emerged - and threatens to destabilize both the traditional packaged food and consumer healthcare industries. We have witnessed enormous pressures in both industries – for example, by private label brands and eroding margins. Fuld’s research shows how two industries combining under pressure is opening a door for nutraceuticals.

Read More

Topics: Consumer Goods, Pharma, Life Sciences

Nutraceuticals: 'Designer Foods' to Grow Through M&A Activity | Pharma Magazine

Posted by Amelia Ehrens on Aug 2, 2012 12:31:00 AM


Scientific rigour and demand for personalised foods will drive these partnerships

A business war game contest on Monday 30th April between Oxford University’s Saïd  and Cambridge’s Judge Business Schools, run by Fuld + Company[1] predicted the outcome of the so-called ‘Battle for Designer Foods’ (nutraceuticals).

Read More

Topics: Pharma, Life Sciences, Merger and Acquisition

5 Competitive Intelligence Misconceptions We Can All Learn From

Posted by Amelia Ehrens on Jul 31, 2012 3:08:00 PM

Competitive intelligence (CI) is good for business, plain and simple.

Competition is a fact of life in the business world. As such, the practice of competitive intelligence has become a commonly accepted and essential part of running a successful company. No one in business questions the need to monitor the moves and strategies of rivals, to takes steps to anticipate and mitigate market threats, and to identify and seize opportunities that may come from this activity. It is only when abuses occur--Hewlett-Packard’s alleged illicit spying on its board, McLaren’s alleged theft of Ferrari’s race car technical secrets, P&G’s dumpster diving for Unilever’’s secrets--that the words “intelligence,” “spying,” “privacy,” and “secrets” become jumbled indiscriminately.

Read More

Topics: Competitive Intelligence

'Generic' medical devices could cut into name-brand profits | The Philadelphia Inquirer

Posted by Amelia Ehrens on Jul 24, 2012 3:57:00 PM

By: David Sell

PHILADELPHIA — Generic competition — a billion-dollar problem for brand-name drug companies since the 1980s — is making inroads in the orthopedic medical devices industry. Last week Cardinal Health Inc., one of the three biggest device wholesalers, said it was increasing its offering of lower-cost products for broken bones.

This nascent trend, borne of increasing pressure to control health care costs, represents a direct threat to brand-name device makers such as West Chester, Pa.-based Synthes, which was bought in June by Johnson & Johnson for $19.7 billion.

Read More

Topics: Value Chain Analysis, Pharma, Healthcare, Life Sciences

Going for the win: Kellogg School of Management

Posted by Amelia Ehrens on Jul 17, 2012 2:40:00 PM

Student teams participated and won in a variety of case competitions this year

Kellogg took the top spot at this public war-game competition, during which students work through analytical exercises to offer companies strategies for achieving competitive advantage in the marketplace. The competition is sponsored and facilitated by Fuld + Co., a research and consulting firm specializing in business and competitive intelligence.

Read More

Robert Galvin, Motorola’s CI Pioneer and how the Joint SCIP-ACI Certification Program Has Built on the Lessons He Taught

Posted by Amelia Ehrens on Jul 10, 2012 4:33:00 PM

Robert Galvin, Motorola’s CI Pioneer and how the Joint SCIP-ACI Certification Program Has Built on the Lessons He Taught
CI Magazine | July 2012 | By Leonard Fuld


Robert Galvin, former chief executive of Motorola and the person most responsible for building the company into a global electronics company, died last October.  Galvin shaped post-World War II Motorola into a technology innovator, the Intel or Cisco of its day.  However there is a back story that Robert Galvin told me about his experience with how government applied intelligence. It was this experience that helped shape Galvin’s view of what has since become known as competitive intelligence. 

Read More

Fuld + Company Blog

The material on this page draws on the research and experience of Fuld + Company thought leaders, consultants and others. Learn more about our expertise here.

Recent Posts

Request for Information

If you'd like someone at Fuld to contact you regarding your strategic competitive challenges, fill out the form below.